Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Combination chemotherapy for soft-tissue sarcomas: a phase III study.

A B Cruz, E A Thames, J B Aust

    Journal of Surgical Oncology
    |January 1, 1979
    PubMed
    Summary

    Adriamycin demonstrated superior efficacy in treating advanced sarcomas compared to combination chemotherapy regimens. This study highlights Adriamycin as a key agent for sarcoma treatment, with potential for enhanced effectiveness in combination therapies.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Effect of preoperative chemotherapy on the outcome of women with operable breast cancer.

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2023
    Same author

    Author Correction: Trans-crustal structural control of CO<sub>2</sub>-rich extensional magmatic systems revealed at Mount Erebus Antarctica.

    Nature communications·2022
    Same author

    Trans-crustal structural control of CO<sub>2</sub>-rich extensional magmatic systems revealed at Mount Erebus Antarctica.

    Nature communications·2022
    Same author

    AN ULTRASTRUCTURAL STUDY OF VEGETATIVE CELL DIVISION IN OEDOGONIUM BORISIANUM(1) (2).

    Journal of phycology·2016
    Same author

    Modelled evaluation of multi-component meningococcal vaccine (Bexsero®) for the prevention of invasive meningococcal disease in infants and adolescents in the UK.

    Epidemiology and infection·2013
    Same author

    A randomized targeted amino acid therapy with behaviourally at-risk adopted children.

    Child: care, health and development·2010

    Area of Science:

    • Medical Oncology
    • Clinical Pharmacology
    • Cancer Research

    Background:

    • Advanced sarcomas are challenging to treat with current chemotherapeutic agents.
    • Optimizing treatment regimens is crucial for improving patient outcomes in sarcoma management.

    Purpose of the Study:

    • To evaluate the efficacy of four different chemotherapy regimens in patients with advanced sarcomas.
    • To compare the response rates and progression times of various drug combinations against single-agent Adriamycin.

    Main Methods:

    • A randomized prospective protocol involving 120 acceptable patients with advanced sarcomas.
    • Four treatment arms were established, utilizing different combinations of actinomycin-D, phenylalanine mustard, vincristine, and Adriamycin.
    • Patients experiencing disease progression in the first three arms were crossed over to Adriamycin treatment.

    Related Experiment Videos

    Main Results:

    • Adriamycin (Treatment 4) showed a statistically significant higher response rate (17%) compared to other regimens.
    • Median time to progression was shortest for Treatment 4 (5 weeks) and Treatment 3 (5 weeks).
    • No significant difference in median survival times was observed across the four treatment arms.

    Conclusions:

    • Adriamycin as a single agent appears superior to the tested drug combinations for advanced sarcomas.
    • Further investigation into Adriamycin in combination with other active agents is warranted to potentially improve efficacy.